Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the Literature

Amr Essa, Jeffrey Macaraeg, Nikhil Jagan, Daniel Kwon, Saboor Randhawa, Matthew Kruse, Stanley Thomas, Manasa Velagapudi, John Horne, Shraddha Narechania, Michael Kaster, Carrie Valenta, Venketraman Sahasranaman, Douglas Moore

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Since the appearance of the E-Cigarette in the early 2000s, its industry, popularity, and prevalence have risen dramatically. In the past, E-Cigarette use with the vaping of nicotine or cannabis products had been associated with a few reported cases of lung injury. However, in 2019, thousands of cases of E-Cigarette or vaping product use-associated lung injury (EVALI) were reported in the United States. Evidence linked this outbreak with vaping of tetrahydrocannabinol (THC). We report two confirmed cases of EVALI and their associated clinical, radiologic, and pathologic features. This report supports the growing body of information regarding EVALI. It also discusses various substances, particularly vitamin E acetate, which has been suggested as a causative agent.

Original languageEnglish (US)
Article number1090629
JournalCase Reports in Pulmonology
Volume2020
DOIs
StatePublished - 2020

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the Literature'. Together they form a unique fingerprint.

Cite this